发明名称 |
AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES |
摘要 |
Compounds of formula (I) and pharmaceutically acceptable salts thereof. As used in formula (I), and throughout the specification, the symbols have the following meanings: R1 and R2 are independently hydrogen, fluorine or alkyl; R3 is aryl or heteroaryl, R4 has various meanings; R5 is hydrogen or alkyl; m is an integer of 0 to 2; and n is an integer of 1 to 3. The compounds of formula (I) are protein kinase inhibitors and are useful in the treatment an d prevention of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of neurodegenerative diseases such as Alzheimer's diseases cardiovascular diseases, viral disease s and fungal diseases.
|
申请公布号 |
CA2394538(A1) |
申请公布日期 |
2001.06.21 |
申请号 |
CA20002394538 |
申请日期 |
2000.12.06 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
WEBSTER, KEVIN R.;POSS, MICHAEL A.;KIMBALL, S. DAVID;MISRA, RAJ N.;RAWLINS, DAVID B.;HAN, WEN-CHING;HUNT, JOHN T.;KIM, KYOUNG S.;CAI, ZHEN-WEI |
分类号 |
C07D277/20;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4709;A61K31/4725;A61K31/497;A61K31/506;A61K45/00;A61P1/00;A61P1/04;A61P9/00;A61P9/10;A61P9/14;A61P17/02;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/16;A61P25/28;A61P29/00;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/04;A61P37/06;A61P43/00;C07D263/00;C07D277/00;C07D277/42;C07D277/44;C07D277/54;C07D417/12;C07D417/14;C07D521/00;(IPC1-7):C07D277/54 |
主分类号 |
C07D277/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|